SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ID Biomedical - Elephant Hunting?? (IDBEF)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Kaiser Soza who wrote ()3/4/1999 1:27:00 PM
From: Ignite44  Read Replies (1) of 27
 
Market reaction to IDBEF's filing for FDA approval of rapid MRSA test has been underwhelming. Why the lack of interest? Are other biotechs developing better or more flexible technologies? Is IDBEF's test perceived as too little too late? Are biotech investors waiting for FDA approval and distribution deals? If approved, what are the odds this product will sell?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News